{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:18:27Z","timestamp":1759033107213},"reference-count":34,"publisher":"American Psychiatric Association Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1998,9,1]]},"DOI":"10.1176\/ajp.155.9.1241","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T19:56:14Z","timestamp":1418846174000},"page":"1241-1246","source":"Crossref","is-referenced-by-count":25,"title":["No Effect of Depression on [<sup>15<\/sup>O]H<sub>2<\/sub>O PET Response to Intravenous <i>d<\/i>-Fenfluramine"],"prefix":"10.1176","volume":"155","author":[{"given":"Jeffrey H.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R161559CEJDJCFI","doi-asserted-by":"crossref","unstructured":"Agren H, Reibring L: PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 1994; 27:2\u20136","DOI":"10.1055\/s-2007-1014265"},{"key":"R161559CEJCGCHB","doi-asserted-by":"crossref","unstructured":"Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR: Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990; 47:411\u2013418","DOI":"10.1001\/archpsyc.1990.01810170011002"},{"key":"R161559CEJBHGBF","doi-asserted-by":"crossref","unstructured":"Asberg M, Traskman L, Thoren P: 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 1976; 33:1193\u20131197","DOI":"10.1001\/archpsyc.1976.01770100055005"},{"key":"R161559CEJDBBIA","doi-asserted-by":"crossref","unstructured":"Yates M, Leake A, Candy JM, Fairbairn AF, McKeith IG, Ferrier IN: 5HT2 receptor changes in major depression. Biol Psychiatry 1990; 27:489\u2013496","DOI":"10.1016\/0006-3223(90)90440-D"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M: 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims\/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993; 614:37\u201344","DOI":"10.1016\/0006-8993(93)91015-K"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D: 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord 1987; 13:67\u201374","DOI":"10.1016\/0165-0327(87)90075-9"},{"key":"R161559CEJDFADC","doi-asserted-by":"crossref","unstructured":"D\u2019haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijsemans M, Kaufman L: SPECT imaging of serotonin2 receptors in depression. Psychiatry Res 1992; 45:227\u2013237","DOI":"10.1016\/0925-4927(92)90018-Y"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Cheetham SC, Crompton MR, Katona CLE, Horton RW: Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 1988; 443:272\u2013280","DOI":"10.1016\/0006-8993(88)91621-6"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Crow TJ, Cross AJ, Cooper SJ, Deakin JF, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE: Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984; 23:1561\u20131569","DOI":"10.1016\/0028-3908(84)90100-X"},{"key":"R161559CEJDHCEH","doi-asserted-by":"crossref","unstructured":"Mayberg HS, Robinson RG, Wong DF, Parikh R, Bolduc P, Starkstein SE, Price T, Dannals RF, Links JM, Wilson AA, Ravert HT, Wagner HN: PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am J Psychiatry 1988; 145:937\u2013943","DOI":"10.1176\/ajp.145.8.937"},{"key":"R161559CEJCDJED","doi-asserted-by":"crossref","unstructured":"Invernizzi R, Berettera C, Garattini S, Samanin R: D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 1986; 120:9\u201315","DOI":"10.1016\/0014-2999(86)90633-3"},{"key":"R161559CEJBJBBD","doi-asserted-by":"crossref","unstructured":"Bonnano G, Fassio A, Severi P, Ruelle A, Raiteri M: Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J Neurochem 1994; 63:1163\u20131166","DOI":"10.1046\/j.1471-4159.1994.63031163.x"},{"key":"R161559CEJDAIFG","doi-asserted-by":"crossref","unstructured":"Heninger GR, Charney DS, Sternberg DE: Serotonergic function in depression. Arch Gen Psychiatry 1984; 41:398\u2013402","DOI":"10.1001\/archpsyc.1984.01790150088012"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S: Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 1984; 34:1029\u20131039","DOI":"10.1016\/0024-3205(84)90016-X"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Lopez-Ibor JJ, Saiz-Ruiz J, Iglesias LM: The fenfluramine challenge test in the affective spectrum: a possible marker of endogeneity and severity. Pharmacopsychiatry 1988; 21:9\u201314","DOI":"10.1055\/s-2007-1014638"},{"key":"R161559CEJCECIG","doi-asserted-by":"crossref","unstructured":"Malone KM, Thase ME, Mieczkowski T, Myers JE, Stull SD, Cooper TB, Mann JJ: Fenfluramine challenge test as a predictor of outcome in major depression. Psychopharmacol Bull 1993; 29:155\u2013161","DOI":"10.1007\/978-1-4757-9498-4_2"},{"key":"R161559CEJBIBGD","doi-asserted-by":"crossref","unstructured":"Kapur S, Meyer J, Wilson AA, Houle S, Brown GM: Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans. Brain Res 1994; 646:292\u2013294","DOI":"10.1016\/0006-8993(94)90091-4"},{"key":"R161559CEJBGCFA","doi-asserted-by":"crossref","unstructured":"Meyer JH, Kapur S, Wilson AA, Dasilva JN, Houle S, Brown GM: Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: an [15O]-H2O PET study in humans. Neurosci Lett 1996; 207:25\u201328","DOI":"10.1016\/0304-3940(96)12479-4"},{"key":"R161559CEJDBFCE","doi-asserted-by":"crossref","unstructured":"Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA: Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996; 153:174\u2013182","DOI":"10.1176\/ajp.153.2.174"},{"key":"R161559CEJDHJCD","doi-asserted-by":"crossref","unstructured":"Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA: Positron emission tomography imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. J Cereb Blood Flow Metab 1996; 16:418\u2013426","DOI":"10.1097\/00004647-199605000-00008"},{"key":"R161559CEJCCBDJ","doi-asserted-by":"crossref","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56\u201362","DOI":"10.1136\/jnnp.23.1.56"},{"key":"R161559CEJBEBFF","doi-asserted-by":"crossref","unstructured":"Kapur S, Meyer J, Wilson AA, Houle S, Brown GM: Activation of specific cortical regions by apomorphine: an [15O]H2O PET study in humans. Neurosci Lett 1994; 176:21\u201324","DOI":"10.1016\/0304-3940(94)90861-3"},{"key":"R161559CEJCDHAJ","doi-asserted-by":"crossref","unstructured":"Hurtig RR, Hichwa RD, O\u2019Leary DS, Boles Ponto LL, Narayana S, Watkins GL, Andreasen NC: Effects of timing and duration of cognitive activation in [15O]water PET studies. J Cereb Blood Flow Metab 1994; 14:423\u2013430","DOI":"10.1038\/jcbfm.1994.53"},{"key":"R161559CEJBJAHA","doi-asserted-by":"crossref","unstructured":"Friston KJ, Frith CD, Liddle PF, Frackowiak RS: Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991; 4:690\u2013699","DOI":"10.1038\/jcbfm.1991.122"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"Friston KJ, Ashburner J, Pollne JB, Frith CD, Heather JD, Frackowiak RSJ: Spatial realignment and normalization of images. Human Brain Mapping 1995; 1:165\u2013189","DOI":"10.1002\/hbm.460030303"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ: Assessing the significance of focal activations using their spatial extent. Human Brain Mapping 1994; 1:214\u2013220","DOI":"10.1002\/hbm.460010306"},{"key":"R161559CEJBBEEA","doi-asserted-by":"crossref","unstructured":"Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 1995; 2:189\u2013210","DOI":"10.1002\/hbm.460020402"},{"key":"R161559CEJCDHDI","doi-asserted-by":"crossref","unstructured":"Kennedy SH, Javanmard M, Vaccarino FJ: A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can J Psychiatry 1997; 42:467\u2013475","DOI":"10.1177\/070674379704200502"},{"key":"R161559CEJCFFGB","doi-asserted-by":"crossref","unstructured":"Duhault J, Beregi L, Roman R: Substituted phenethylamines and anorexia. Prog Neuropsychopharmacol 1980; 4:341\u2013349","DOI":"10.1016\/0364-7722(80)90004-1"},{"key":"R161559CEJBDCFI","doi-asserted-by":"crossref","unstructured":"Fuller RW, Snoddy HD, Hemrick SK: Effects of fenfluramine and norfenfluramine on brain serotonin metabolism in rats. Proc Soc Exp Biol Med 1978; 157:202\u2013205","DOI":"10.3181\/00379727-157-40021"},{"key":"R161559CEJBJEGC","doi-asserted-by":"crossref","unstructured":"Parsons AA, Whalley ET, Feniuk W, Connor HE, Humphrey PP: 5-HT1 like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 1989; 96:434\u2013449","DOI":"10.1111\/j.1476-5381.1989.tb11835.x"},{"key":"R161559CEJCFDCH","doi-asserted-by":"crossref","unstructured":"Hamel E, Bouchard D: Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites. Br J Pharmacol 1991; 102:227\u2013233","DOI":"10.1111\/j.1476-5381.1991.tb12158.x"},{"key":"R161559CEJDEEFA","doi-asserted-by":"crossref","unstructured":"Jansen I, Olesen J, Edvinsson I: 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 1993; 147:141\u2013150","DOI":"10.1111\/j.1748-1716.1993.tb09483.x"},{"key":"R161559CEJEAAFB","doi-asserted-by":"crossref","unstructured":"McBean DE, Sharkley J, Ritchie IM, Kelly PAT: Cerebrovascular and functional consequences of 5-HT1A receptor activation. Brain Res 1991; 555:159\u2013163","DOI":"10.1016\/0006-8993(91)90873-T"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.155.9.1241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T18:54:37Z","timestamp":1721847277000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.155.9.1241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9,1]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1998,9,1]]}},"alternative-id":["10.1176\/ajp.155.9.1241"],"URL":"https:\/\/doi.org\/10.1176\/ajp.155.9.1241","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9,1]]}}}